Abstract
The iron requirement for breastfed infants remains controversial. Given the impact of iron on neurodevelopmental outcomes and the questionable impact of iron supplements after iron deficiency has occurred, its importance as a nutrient in this population cannot be down played. Infants are born with relatively large body stores of iron that are marginally related to maternal iron status in developed countries. Delayed cord clamping may increase these fetal stores, but at the present time this is only recommended for preterm infants who are born with low iron stores. The diagnosis of iron deficiency (ID) and iron deficiency anemia (IDA) remains problematic though new laboratory tests (measures of reticulocyte hemoglobin concentration and serum transferrin receptor) hold promise in developed countries. The present evidence supports the potential benefits of iron supplementation of exclusively breastfed infants after 4 months of age, by which time the iron stores present at birth are depleted. This deficit cannot be made up even if the small amounts of iron in human milk are completely absorbed.
Keywords: Breastfeeding, infants, iron deficiency, iron deficiency anemia, neurodevelopment.
Current Pediatric Reviews
Title:How Much Iron is Needed for Breastfeeding Infants?
Volume: 11 Issue: 4
Author(s): Frank R. Greer
Affiliation:
Keywords: Breastfeeding, infants, iron deficiency, iron deficiency anemia, neurodevelopment.
Abstract: The iron requirement for breastfed infants remains controversial. Given the impact of iron on neurodevelopmental outcomes and the questionable impact of iron supplements after iron deficiency has occurred, its importance as a nutrient in this population cannot be down played. Infants are born with relatively large body stores of iron that are marginally related to maternal iron status in developed countries. Delayed cord clamping may increase these fetal stores, but at the present time this is only recommended for preterm infants who are born with low iron stores. The diagnosis of iron deficiency (ID) and iron deficiency anemia (IDA) remains problematic though new laboratory tests (measures of reticulocyte hemoglobin concentration and serum transferrin receptor) hold promise in developed countries. The present evidence supports the potential benefits of iron supplementation of exclusively breastfed infants after 4 months of age, by which time the iron stores present at birth are depleted. This deficit cannot be made up even if the small amounts of iron in human milk are completely absorbed.
Export Options
About this article
Cite this article as:
Greer R. Frank, How Much Iron is Needed for Breastfeeding Infants?, Current Pediatric Reviews 2015; 11 (4) . https://dx.doi.org/10.2174/1573396311666150731112726
DOI https://dx.doi.org/10.2174/1573396311666150731112726 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cystic Fibrosis Related Diabetes Mellitus - Diagnostic and Management Challenges
Current Diabetes Reviews Diagnosis and Treatment of Unilateral Forms of Primary Aldosteronism
Current Hypertension Reviews Small Animal Computed Tomography Imaging
Current Medical Imaging Organ Preference of Cancer Metastasis and Metastasis-Related Cell Adhesion Molecules Including Carbohydrates
Cardiovascular & Hematological Disorders-Drug Targets Medicinal Chemistry of Antimigraine Drugs
Current Medicinal Chemistry Methylene Blue not Contraindicated in Treating Hemodynamic Instability in Pediatric and Neonate Patients
Current Pediatric Reviews Selected Herbals for Sports Injuries
The Natural Products Journal A Review of Current Treatment Strategies for Varicose Veins
Recent Patents on Cardiovascular Drug Discovery Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer’s Disease: A Translational Overview
Current Pharmaceutical Design Bleeding, Vertebral Fractures and Vascular Calcifications in Patients Treated with Warfarin: Hope for Lower Risks with Alternative Therapies
Current Vascular Pharmacology PARADIGM - HF: The Rise of the Arnis
Reviews on Recent Clinical Trials Growing Collateral Arteries On Demand
Recent Patents on Cardiovascular Drug Discovery Calcium Related Genes in Dogs as Potential Cardiac Biomarkers for the Detection of Chronic Mitral Valve Disease
Recent Patents on Biomarkers Activated Protein C and Acute Kidney Injury: Selective Targeting of PAR-1
Current Drug Targets Diagnosis of Alterations of Serum Calcium Metabolism
Medicinal Chemistry Pharmacotherapy in Neonatal and Pediatric Extracorporeal Membrane Oxygenation (ECMO)
Current Drug Metabolism Biomarkers Determining Cardiovascular Risk in Patients with Kidney Disease
Current Medicinal Chemistry The Treatment of Painful Diabetic Neuropathy
Current Diabetes Reviews Acute Kidney Injury in Pediatric Heart Failure
Current Cardiology Reviews Progress in the Oral Treatment of Type 2 Diabetes: Update on DPP-IV Inhibitors
Current Diabetes Reviews